In furtherance to the Board meeting notice dated 06-11-2025, we wish inform you that at the meeting of Board of Directors of M/s.Phyto Chem (India) Limited held today i.e., on 14-11-2025, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Phyto Chem (India) Ltd reported continued losses for Q2 FY26 with revenue from operations of Rs. 436.45 lakhs and a net loss of Rs. 55.75 lakhs (EPS of Rs. -1.30). For the half year ended September 2025, revenue from operations fell sharply to Rs. 586.77 lakhs from Rs. 897.55 lakhs in H1 FY25, a drop of roughly 35%. The company posted a net loss of Rs. 104.20 lakhs for H1 FY26 versus a loss of Rs. 135.70 lakhs in H1 FY25. Total expenses of Rs. 767.15 lakhs exceeded total revenue of Rs. 657.36 lakhs. Other equity eroded from Rs. 208.75 lakhs to Rs. 105.68 lakhs, reflecting accumulated losses. The statutory auditors issued an unmodified limited review report.
Persistent losses, shrinking revenue, and weakening equity are negative for shareholders and signal continued stress. With total borrowings around Rs. 1,478 lakhs against equity of Rs. 535.70 lakhs (debt-equity near 2.8x), financial risk remains elevated and the stock may remain under pressure until the company returns to profitability.